Blonde L - Search Results

1

Association among weight change, glycemic control, and markers of cardiovascular risk with exenatide once weekly: a pooled analysis of patients with type 2 diabetes.

Blonde L, Pencek R, MacConell L. Blonde L, et al. Cardiovasc Diabetol. 2015 Feb 3;14:12. doi: 10.1186/s12933-014-0171-2. Cardiovasc Diabetol. 2015. PMID: 25645567 Free PMC article. Clinical Trial.

2

Current challenges in diabetes management.

Blonde L. Blonde L. Clin Cornerstone. 2005;7 Suppl 3:S6-17. doi: 10.1016/s1098-3597(05)80084-5. Clin Cornerstone. 2005. PMID: 16545737 Review.

3

Interim analysis of the effects of exenatide treatment on A1C, weight and cardiovascular risk factors over 82 weeks in 314 overweight patients with type 2 diabetes.

Blonde L, Klein EJ, Han J, Zhang B, Mac SM, Poon TH, Taylor KL, Trautmann ME, Kim DD, Kendall DM. Blonde L, et al. Diabetes Obes Metab. 2006 Jul;8(4):436-47. doi: 10.1111/j.1463-1326.2006.00602.x. Diabetes Obes Metab. 2006. PMID: 16776751 Clinical Trial.

4

Sildenafil citrate for erectile dysfunction in men with diabetes and cardiovascular risk factors: a retrospective analysis of pooled data from placebo-controlled trials.

Blonde L. Blonde L. Curr Med Res Opin. 2006 Nov;22(11):2111-20. doi: 10.1185/030079906X148256. Curr Med Res Opin. 2006. PMID: 17076971

5

State of diabetes care in the United States.

Blonde L. Blonde L. Am J Manag Care. 2007 Apr;13 Suppl 2:S36-40. Am J Manag Care. 2007. PMID: 17417931 Free article. Review.

6

Patient-directed titration for achieving glycaemic goals using a once-daily basal insulin analogue: an assessment of two different fasting plasma glucose targets - the TITRATE study.

Blonde L, Merilainen M, Karwe V, Raskin P; TITRATE Study Group. Blonde L, et al. Diabetes Obes Metab. 2009 Jun;11(6):623-31. doi: 10.1111/j.1463-1326.2009.01060.x. Diabetes Obes Metab. 2009. PMID: 19515182 Clinical Trial.

7

The safety and efficacy of liraglutide with or without oral antidiabetic drug therapy in type 2 diabetes: an overview of the LEAD 1-5 studies.

Blonde L, Russell-Jones D. Blonde L, et al. Diabetes Obes Metab. 2009 Dec;11 Suppl 3:26-34. doi: 10.1111/j.1463-1326.2009.01075.x. Diabetes Obes Metab. 2009. PMID: 19878259 Review.

8

Current antihyperglycemic treatment strategies for patients with type 2 diabetes mellitus.

Blonde L. Blonde L. Cleve Clin J Med. 2009 Dec;76 Suppl 5:S4-11. doi: 10.3949/ccjm.76.s5.02. Cleve Clin J Med. 2009. PMID: 19952303 Free article. Review.

9

Switching to once-daily liraglutide from twice-daily exenatide further improves glycemic control in patients with type 2 diabetes using oral agents.

Buse JB, Sesti G, Schmidt WE, Montanya E, Chang CT, Xu Y, Blonde L, Rosenstock J; Liraglutide Effect Action in Diabetes-6 Study Group. Buse JB, et al. Among authors: blonde l. Diabetes Care. 2010 Jun;33(6):1300-3. doi: 10.2337/dc09-2260. Epub 2010 Mar 23. Diabetes Care. 2010. PMID: 20332351 Free PMC article. Clinical Trial.

10

Benefits and risks for intensive glycemic control in patients with diabetes mellitus.

Blonde L. Blonde L. Am J Med Sci. 2012 Jan;343(1):17-20. doi: 10.1097/MAJ.0b013e31823ea23e. Am J Med Sci. 2012. PMID: 22205061 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

201 results

Search Page